Exaggerated hypertensive response to combretastatin A-4 phosphate in hypertensive rats: Effective pharmacological inhibition by diltiazem
Author:
Funder
OXiGENE, Inc.
Publisher
Elsevier BV
Subject
Pharmacology,Molecular Medicine,Physiology
Reference38 articles.
1. Interactions of combretastatin, a new plant-derived antimitotic agent, with tubulin;Hamel;Biochem Pharmacol,1983
2. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41;Pettit;J Med Chem,2005
3. Current development status of small-molecule vascular disrupting agents;Chaplin;Curr Opin Investig Drugs,2006
4. A phase I trial of radioimmunotherapy with 131I-A5B7 anti-CEA antibody in combination with combretastatin-A4-phosphate in advanced gastrointestinal carcinomas;Meyer;Clin Cancer Res,2009
5. A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer;Rustin;Br J Cancer,2010
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anti‐tumor and cardiotoxic effects of microtubule polymerization inhibitors: The mechanisms and management strategies;Journal of Applied Toxicology;2023-07-26
2. Vascular Disrupting Agents in cancer treatment: Cardiovascular toxicity and implications for co-administration with other cancer chemotherapeutics;Pharmacology & Therapeutics;2019-10
3. A single dose of intravenous combretastatin A4-phosphate is reasonably well tolerated and significantly reduces tumour vascularization in canine spontaneous cancers;Veterinary and Comparative Oncology;2018-05-24
4. Clinical trial experience with CA4P anticancer therapy: focus on efficacy, cardiovascular adverse events, and hypertension management;Gynecologic Oncology Research and Practice;2018-01-05
5. A dose-escalation study of combretastatin A4-phosphate in healthy dogs;Veterinary and Comparative Oncology;2017-06-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3